These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 28421299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis.
    Fu X, Zhang S, Gao F, Mao N.
    Clin Nephrol; 2024 Oct; 102(4):223-231. PubMed ID: 38994592
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K, Flynn J, Okamura D, Zhou L.
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [Abstract] [Full Text] [Related]

  • 5. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2136-42. PubMed ID: 26576619
    [Abstract] [Full Text] [Related]

  • 6. Calcium-Polystyrene Sulfonate Decreases Inter-Dialytic Hyperkalemia in Patients Undergoing Maintenance Hemodialysis: A Prospective, Randomized, Crossover Study.
    Wang J, Lv MM, Zach O, Wang LY, Zhou MY, Song GR, Zhang X, Lin HL.
    Ther Apher Dial; 2018 Dec 07; 22(6):609-616. PubMed ID: 30109784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of hyperkalemia in hospitalized patients.
    Fordjour KN, Walton T, Doran JJ.
    Am J Med Sci; 2014 Feb 07; 347(2):93-100. PubMed ID: 23255245
    [Abstract] [Full Text] [Related]

  • 9. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE, Farrington CA, Wall GC, Belz MM.
    Clin Nephrol; 2016 Jan 07; 85(1):38-43. PubMed ID: 26587776
    [Abstract] [Full Text] [Related]

  • 10. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J, Moffett BS.
    Pediatr Nephrol; 2016 Nov 07; 31(11):2113-7. PubMed ID: 27215929
    [Abstract] [Full Text] [Related]

  • 11. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
    Kessler C, Ng J, Valdez K, Xie H, Geiger B.
    J Hosp Med; 2011 Mar 07; 6(3):136-40. PubMed ID: 21387549
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M, Shea A, Giguère P, Nguyen ML.
    Ann Pharmacother; 2016 Jun 07; 50(6):455-62. PubMed ID: 27048188
    [Abstract] [Full Text] [Related]

  • 13. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020 Jun 07; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

  • 14. Effects of the Potassium-Binding Polymer Patiromer on Markers of Mineral Metabolism.
    Bushinsky DA, Spiegel DM, Yuan J, Warren S, Fogli J, Pergola PE.
    Clin J Am Soc Nephrol; 2019 Jan 07; 14(1):103-110. PubMed ID: 30381412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy.
    Chernin G, Gal-Oz A, Ben-Assa E, Schwartz IF, Weinstein T, Schwartz D, Silverberg DS.
    Clin Cardiol; 2012 Jan 07; 35(1):32-6. PubMed ID: 22057933
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada.
    Atiquzzaman M, Birks P, Bevilacqua M, Wong MMY, Zheng Y, Djurdjev O, Levin A.
    Can J Kidney Health Dis; 2022 Jan 07; 9():20543581221137177. PubMed ID: 36406867
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of Appropriate Sodium Polystyrene Sulfonate Use With a Hyperkalemia Order Set: A Pilot Study.
    Mueller ZT, Crannage AJ.
    J Pharm Pract; 2019 Oct 07; 32(5):493-498. PubMed ID: 29642732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.